Eyebright Medical Technology Beijing Co Ltd (688050) — Cash Flow Reinvestment Rate
Eyebright Medical Technology Beijing Co Ltd (688050) has a Cash Flow Reinvestment Rate of 0.28x as of September 2025, reinvesting CN¥21.37 Million (capex CN¥21.37 Million ) from operating cash flow of CN¥76.92 Million. Check 688050 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Eyebright Medical Technology Beijing Co Ltd Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Eyebright Medical Technology Beijing Co Ltd across 9 annual periods. Explore how well can Eyebright Medical Technology Beijing Co service its debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Eyebright Medical Technology Beijing Co Ltd (2017–2025)
Year-by-year capital reinvestment analysis for Eyebright Medical Technology Beijing Co Ltd. For live market cap and broader valuation context, see 688050 company net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.35x | CN¥130.32 Million | CN¥369.15 Million | CN¥123.14 Million | ▼ -77.3% |
| 2024 | 1.56x | CN¥541.48 Million | CN¥347.75 Million | CN¥329.48 Million | ▼ -12.6% |
| 2023 | 1.78x | CN¥403.01 Million | CN¥226.27 Million | CN¥370.34 Million | ▼ -23.0% |
| 2022 | 2.31x | CN¥578.87 Million | CN¥250.13 Million | CN¥271.03 Million | ▼ -30.6% |
| 2021 | 3.34x | CN¥731.58 Million | CN¥219.30 Million | CN¥311.22 Million | ▼ -41.7% |
| 2020 | 5.73x | CN¥706.44 Million | CN¥123.35 Million | CN¥118.73 Million | ▲ +40.7% |
| 2019 | 4.07x | CN¥205.59 Million | CN¥50.49 Million | CN¥141.61 Million | ▲ +80.4% |
| 2018 | 2.26x | CN¥71.81 Million | CN¥31.82 Million | CN¥71.81 Million | ▼ -70.3% |
| 2017 | 7.60x | CN¥31.53 Million | CN¥4.15 Million | CN¥31.53 Million | — |